Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulation by neural stem cells.

Tamir Ben-Hur1

  • 1Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel. tamir@hadassah.org.il

Journal of the Neurological Sciences
|June 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pro-repair properties of a human embryonic stem cell-derived astrocyte cell therapy in demyelinating disorders.

Stem cell reports·2026
Same author

High-intensity exercise training alters gut microbiota to mitigate the development of experimental autoimmune encephalomyelitis.

Scientific reports·2026
Same author

Corrigendum to "The paradoxical protective effect of chronic stress on advanced Alzheimer's disease pathology". [Brain, Behav., Immun. 132 (2026) 106224].

Brain, behavior, and immunity·2026
Same author

The paradoxical protective effect of chronic stress on advanced Alzheimer's disease pathology.

Brain, behavior, and immunity·2025
Same author

National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel.

Therapeutic advances in neurological disorders·2025
Same author

Medical risk factors, ApoE haplotype, and Alzheimer's disease: a large-scale analysis.

The journal of prevention of Alzheimer's disease·2025
Same journal

Distinguishing drug-target effects from natural lipid variation and incorporating imaging outcomes in Mendelian randomisation studies of multiple sclerosis.

Journal of the neurological sciences·2026
Same journal

Long-term social cognitive impairment after ischemic stroke: Frequency and association with lesion volume and location in an exploratory pilot study.

Journal of the neurological sciences·2026
Same journal

Subjective cognitive decline among U.S. Cancer survivors, 2017-2024: Prevalence, cancer-specific patterns, and associated factors.

Journal of the neurological sciences·2026
Same journal

Comment on "Comparative impact of mental and cardiovascular comorbidities on adverse outcomes in people with MS".

Journal of the neurological sciences·2026
Same journal

Comment on "Efficacy and safety of conventional immunosuppressant therapies in elderly patients with Neuromyelitis optica spectrum disorder: A target trial emulation study".

Journal of the neurological sciences·2026
Same journal

Increasing incidence of varicella-zoster virus meningitis in Japan, 2011-2022.

Journal of the neurological sciences·2026
See all related articles

Neural precursor cells (NPCs) show promise for treating central nervous system (CNS) inflammation. Transplanted NPCs can reduce disease severity in models of multiple sclerosis by both regenerating tissue and suppressing immune responses.

Area of Science:

  • Neuroscience
  • Immunology
  • Regenerative Medicine

Background:

  • Neural (stem) cell transplantation is a potential cell replacement therapy.
  • Multipotential neural precursor cells (NPCs) demonstrate remyelinating potential in demyelinated lesions.

Purpose of the Study:

  • To investigate the therapeutic potential of neural precursor cells (NPCs) in central nervous system (CNS) inflammation and demyelinating diseases.
  • To evaluate the regenerative and immunomodulatory effects of NPCs in experimental autoimmune encephalomyelitis (EAE) models.

Main Methods:

  • Transplantation of NPCs into the CNS and intravenous administration in rodent models of EAE.
  • Assessment of cell migration using magnetic resonance imaging.
  • Evaluation of clinical disease severity, demyelination, axonal pathology, and immune cell responses.

Related Experiment Videos

Main Results:

  • Intraventricular NPC transplantation attenuated brain inflammation, reduced disease severity, and lessened demyelination and axonal damage in EAE.
  • Intravenous NPC administration inhibited EAE by inducing peripheral immunosuppression, reducing T cell activation and proliferation in lymph nodes.
  • NPCs migrated to inflamed white matter in the CNS but did not enter gray matter when transplanted directly.

Conclusions:

  • Neural precursor cells possess both regenerative and immunomodulatory properties beneficial for treating CNS inflammatory diseases like multiple sclerosis.
  • Optimizing cell therapy for MS should leverage both the tissue repair and immune-suppressing capabilities of NPCs.
  • Intravenous administration of NPCs offers a therapeutic strategy through peripheral immune modulation, inhibiting T cell responses detrimental to the CNS.